Skip to main content
Premium Trial:

Request an Annual Quote

Aveo Pharmaceuticals Licenses GeneGo's MetaCore Suite 4.5

NEW YORK (GenomeWeb News) — GeneGo said yesterday that Aveo Pharmaceuticals has licensed its MetaCore 4.5 data-mining suite.
 
The latest version of the suite has disease enrichment and functional ontology functions, and is used to help target, select, and validate biomarkers.
 
The suite, which can concurrently visualize gene expression, proteomics, genetic, and metabolic data, has a management system that can be used to upload and handle thousands of genome-wide files, the company said.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.